BCAB - BioAtla, Inc. (BCAB) Q4 2024 Earnings Call Transcript
2025-03-27 18:18:03 ET
BioAtla, Inc. (BCAB)
Q4 2024 Earnings Conference Call
March 27, 2025 4:30 p.m. ET
Company Participants
Bruce Mackle - LifeSci Advisors, Investor Relations
Jay Short - Chairman, Chief Executive Officer and Cofounder
Richard Waldron - Chief Financial Officer
Eric Sievers - Chief Medical Officer
Sheri Lydick - Chief Commercial Officer
Conference Call Participants
Jeet Mukherjee - BTIG
Tony Butler - Rodman & Renshaw
Arthur He - H.C. Wainwright
Presentation
Operator
Good day, everyone, and welcome to today's BioAtla Fourth Quarter and Fiscal Year 2024 Earnings Call. At this time, all participants are in a listen-only mode. Later we will have the opportunity to ask questions during the question-and-answer session. [Operator Instructions]
It is now my pleasure to turn the conference over to Mr. Bruce Mackle of LifeSci Advisors. Please go ahead, sir.
Bruce Mackle
Thank you, Operator, and good afternoon, everyone. With me today on the phone from BioAtla are Dr. Jay Short, Chairman, CEO, and Cofounder; and Richard Waldron, Chief Financial Officer. Following today's call, Dr. Eric Sievers, Chief Medical Officer; and Sheri Lydick, Chief Commercial Officer, will join Jay and Rick in a short Q&A.
Earlier this afternoon, BioAtla released financial results and a business update for the fourth quarter and full-year ended December 31, 2024. A copy of the press release and corporate presentation are available on the company's website....
BioAtla, Inc. (BCAB) Q4 2024 Earnings Call Transcript